SNIPR BIOME

Denmark - Copenhagen

Biotechnology

Focus: CRISPR for microbiome management, genetically-modified bacteriophages

SNIPR BIOME is a life sciences company focused on CRISPR for microbiome management, genetically-modified bacteriophages.

Gene TherapyRare DiseasesGastroenterology

Funding Stage

SERIES A

Employees

1-50

Total Funding

$50M

Open Jobs

Pipeline & Clinical Trials

SNIPR001

E.Coli Infections

Phase 1

Clinical Trials (1)

NCT05277350A Study Investigating the Safety, Recovery, and Pharmacodynamics of Multiple Oral Administrations of SNIPR001 in Healthy Subjects

Phase 1

SNIPR001 consists of genetically modified bacteriophages specifically targeting Escherichia coli

E Coli Infections

Phase 1/2

Clinical Trials (1)

NCT06938867Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

Phase 1/2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials